Limited coverage criteria perindopril (ACE inhibitors)

Last updated on March 24, 2025

 

Return to Special Authority drug list

Generic name

perindopril                     

Strength & form

2 mg/4 mg/8 mg, tablet

Special Authority criteria

Approval period

Treatment failure on optimal dose of, or intolerance to, ramipril

OR

Complex patient requiring medications for co-existing chronic condition(s)

Indefinite

Practitioner exemptions

The following practitioners are not required to submit a Special Authority request for coverage:

  • Pediatric cardiology
  • Pediatrics

Special notes

  • PharmaCare does not cover perindopril in combination with indapamide
  • Patients with co-existing chronic conditions requiring use of multiple medications will be considered complex for the purposes of Special Authority criteria

Special Authority request form(s)